HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert H Palmer Selected Research

Milnacipran (Ixel)

6/2015Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program.
6/2014Effects of milnacipran on the multidimensional aspects of fatigue and the relationship of fatigue to pain and function: pooled analysis of 3 fibromyalgia trials.
4/2014Milnacipran effects on 24-hour ambulatory blood pressure and heart rate in fibromyalgia patients: a randomized, placebo-controlled, dose-escalation study.
1/2014Efficacy of long-term milnacipran treatment in patients meeting different thresholds of clinically relevant pain relief: subgroup analysis of a randomized, double-blind, placebo-controlled withdrawal study.
12/2013A 3-year, open-label, flexible-dosing study of milnacipran for the treatment of fibromyalgia.
8/2013Continuing efficacy of milnacipran following long-term treatment in fibromyalgia: a randomized trial.
6/2013Milnacipran combined with pregabalin in fibromyalgia: a randomized, open-label study evaluating the safety and efficacy of adding milnacipran in patients with incomplete response to pregabalin.
1/2013Results of switching to milnacipran in fibromyalgia patients with an inadequate response to duloxetine: a phase IV pilot study.
7/2012Relationships among pain, depressed mood, and global status in fibromyalgia patients: post hoc analyses of a randomized, placebo-controlled trial of milnacipran.
5/2012Short-term (2-week) effects of discontinuing milnacipran in patients with fibromyalgia.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert H Palmer Research Topics

Disease

19Fibromyalgia (Fibrositis)
06/2015 - 11/2008
14Pain (Aches)
06/2015 - 11/2008
8Nausea
04/2014 - 11/2008
5Fatigue
06/2014 - 11/2008
4Constipation
01/2018 - 11/2008
3Headache (Headaches)
03/2011 - 11/2008
2Body Weight (Weight, Body)
06/2017 - 01/2012
2Dizziness (Lightheadedness)
06/2013 - 01/2013
1Autism Spectrum Disorder
11/2019
1Pneumonia (Pneumonitis)
06/2017
1Mood Disorders (Mood Disorder)
06/2017
1Autistic Disorder (Autism)
06/2017
1Polyps
01/2017
1Stomach Neoplasms (Stomach Cancer)
01/2017
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2016
1Hemorrhage
11/2015
1Sleepiness
06/2013
1Overweight
01/2012
1Weight Loss (Weight Reduction)
01/2012
1Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
01/2003

Drug/Important Bio-Agent (IBA)

19Milnacipran (Ixel)FDA Link
06/2015 - 11/2008
3Norepinephrine (Noradrenaline)FDA LinkGeneric
08/2010 - 11/2008
2Memantine (Namenda)FDA Link
11/2019 - 06/2017
2Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
02/2009 - 11/2008
1Bile Acids and Salts (Bile Acids)IBA
01/2018
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
06/2017
1N-Methylaspartate (NMDA)IBA
06/2017
1Proton Pump InhibitorsIBA
01/2017
1Ursodeoxycholic Acid (Urso)FDA LinkGeneric
01/2016
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
11/2015
1AnticoagulantsIBA
11/2015
1Pharmaceutical PreparationsIBA
06/2015
1Pregabalin (Lyrica)FDA Link
06/2013
1Duloxetine Hydrochloride (Cymbalta)FDA Link
01/2013
1Serotonin (5 Hydroxytryptamine)IBA
08/2010
1alosetron (Lotronex)FDA Link
01/2003

Therapy/Procedure

2Aftercare (After-Treatment)
01/2014 - 03/2011
1Therapeutics
01/2013